An emerging probiotic with liver health benefits for smokers

Wei Jia; Xiaojiao Zheng

doi:10.1093/lifemeta/loac033

An emerging probiotic with liver health benefits for smokers

Wei Jia^*, Xiaojiao Zheng

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › peer-review

1 Citation (Scopus)

Abstract

Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.

Original language	English
Article number	loac033
Number of pages	2
Journal	Life Metabolism
Volume	2
Issue number	1
DOIs	https://doi.org/10.1093/lifemeta/loac033
Publication status	Published - Feb 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/lifemeta/loac033

Cite this

@article{07afe90807674d0399278e4397a490d8,

title = "An emerging probiotic with liver health benefits for smokers",

abstract = "Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.",

author = "Wei Jia and Xiaojiao Zheng",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s).",

year = "2023",

month = feb,

doi = "10.1093/lifemeta/loac033",

language = "English",

volume = "2",

journal = "Life Metabolism",

issn = "2097-2555",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - An emerging probiotic with liver health benefits for smokers

AU - Jia, Wei

AU - Zheng, Xiaojiao

PY - 2023/2

Y1 - 2023/2

N2 - Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.

AB - Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.

UR - http://www.scopus.com/inward/record.url?scp=85162755762&partnerID=8YFLogxK

U2 - 10.1093/lifemeta/loac033

DO - 10.1093/lifemeta/loac033

M3 - Journal article

AN - SCOPUS:85162755762

SN - 2097-2555

VL - 2

JO - Life Metabolism

JF - Life Metabolism

IS - 1

M1 - loac033

ER -

An emerging probiotic with liver health benefits for smokers

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this